[go: up one dir, main page]

NL7010558A - - Google Patents

Info

Publication number
NL7010558A
NL7010558A NL7010558A NL7010558A NL7010558A NL 7010558 A NL7010558 A NL 7010558A NL 7010558 A NL7010558 A NL 7010558A NL 7010558 A NL7010558 A NL 7010558A NL 7010558 A NL7010558 A NL 7010558A
Authority
NL
Netherlands
Application number
NL7010558A
Other versions
NL165653B (nl
NL165653C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7010558A publication Critical patent/NL7010558A/xx
Publication of NL165653B publication Critical patent/NL165653B/xx
Application granted granted Critical
Publication of NL165653C publication Critical patent/NL165653C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL7010558.A 1969-07-21 1970-07-16 Werkwijze voor het bereiden van een waterige oplossing van een imidazo-Ÿ2,1-bŸ-thiazool, die in farmaceutisch opzicht geschikt is om door injectie te worden toege- diend aan warmbloedige dieren. NL165653C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (3)

Publication Number Publication Date
NL7010558A true NL7010558A (de) 1971-01-25
NL165653B NL165653B (nl) 1980-12-15
NL165653C NL165653C (nl) 1981-05-15

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7010558.A NL165653C (nl) 1969-07-21 1970-07-16 Werkwijze voor het bereiden van een waterige oplossing van een imidazo-Ÿ2,1-bŸ-thiazool, die in farmaceutisch opzicht geschikt is om door injectie te worden toege- diend aan warmbloedige dieren.

Country Status (9)

Country Link
US (1) US3670086A (de)
BE (1) BE753710A (de)
CA (1) CA964193A (de)
DE (1) DE2036114C3 (de)
FR (1) FR2059541B1 (de)
GB (1) GB1287673A (de)
IE (1) IE34373B1 (de)
NL (1) NL165653C (de)
ZA (1) ZA704419B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
US7648997B2 (en) 2003-08-12 2010-01-19 Coley Pharmaceutical Group, Inc. Hydroxylamine substituted imidazoquinolines
EP1658076B1 (de) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy- und arylalkylenoxy-substituierte imidazochinoline
EP1660026A4 (de) 2003-09-05 2008-07-16 3M Innovative Properties Co Behandlung von cd5+ b-zell-lyphom
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
NZ546273A (en) 2003-10-03 2009-05-31 Coley Pharm Group Inc Alkoxy substituted imidazoquinolines
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
EP1701955A1 (de) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl- und arylalkinylsubstituierte imidazochinoline
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (de) 2004-03-24 2006-12-13 3M Innovative Properties Company Amidsubstituierte imidazopyridine, imidazochinoline und imidazonaphthyridine
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
CN101443005A (zh) * 2004-12-30 2009-05-27 科勒制药集团公司 免疫反应调节制剂和方法
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (de) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
NL165653B (nl) 1980-12-15
FR2059541B1 (de) 1974-10-11
IE34373L (en) 1971-01-21
ZA704419B (en) 1971-04-28
DE2036114B2 (de) 1979-01-18
DE2036114A1 (de) 1971-02-04
IE34373B1 (en) 1975-04-16
BE753710A (fr) 1970-12-31
GB1287673A (en) 1972-09-06
US3670086A (en) 1972-06-13
FR2059541A1 (de) 1971-06-04
NL165653C (nl) 1981-05-15
CA964193A (en) 1975-03-11
DE2036114C3 (de) 1979-09-13

Similar Documents

Publication Publication Date Title
AU2270770A (de)
AU465452B2 (de)
AU429630B2 (de)
AU450150B2 (de)
AU5712069A (de)
AU2355770A (de)
AU470301B1 (de)
AU427401B2 (de)
AU442554B2 (de)
AU417208B2 (de)
AU410358B2 (de)
AU438128B2 (de)
AU428131B2 (de)
AU442285B2 (de)
AU442322B2 (de)
AU442380B2 (de)
AU442463B2 (de)
AU442535B2 (de)
AU442538B2 (de)
AT308690B (de)
AU470661B1 (de)
AU428129B2 (de)
AU414607B2 (de)
AU428074B2 (de)
AU1036070A (de)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent